Dr. Schuchter Discusses Managing Ipilimumab's Side Effects

onclivetv has 407 videos Subscribe Here

Description: Visit for more videos.

Lynn M. Schuchter, MD, division chief of hematology-oncology at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia discusses managing the ipilimumab (Yervoy) side effects. She specifically mentions the risk management evaluation and mitigation strategy (REMS) program that the FDA required as part of its approval and what can be done above the REMS program.
Shared By : onclivetv
Posted on : 07/13/11
Added : 6 years ago
Category : General

More From onclivetv

Nothing found.